GENEVA, Oct. 1 -- SYNG PHARMACEUTICALS INC. filed a patent application (CA2026/050397) for “A METHOD AND APPARATUS FOR ASSESSING A PRESENCE OF ENDOMETRIOSIS USING NON-INVASIVE DUAL BIOMARKERS”. With publication no. WO/2026/188341, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: G01N 33/48
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....